首页 > 最新文献

Vascular and endovascular surgery最新文献

英文 中文
Study Protocol for a Focus Group Discussion About the Patients' Perspective on Carotid Endarterectomy. 关于患者对颈动脉内膜剥脱术看法的焦点小组讨论研究方案。
Pub Date : 2025-04-01 Epub Date: 2024-09-21 DOI: 10.1177/15385744241286585
M S Marsman, G G Koning, B P W Jansen, M M P J Reijnen, M Habibovic, P W H E Vriens

Introduction: The outcomes of carotid surgery are commonly evaluated using parameters such as mortality and stroke. The importance of these parameters is based on doctors' and scientific perspectives. Presently, patient centered health care aims to value the evaluation from patients' perspective, mostly using Patient-Reported Outcomes (PROs). The true significance of outcomes of carotid surgery that matter most to the patients is largely unknown. The aim of this study is to identify and verify the patients' perspective on carotid surgery for patients with a symptomatic and significant carotid stenosis.

Methods and outcomes: An exploratory semi-structured focus group discussion will be used, as a quality research method. Three groups consisting of 8 patients (n = 24), who underwent the carotid endarterectomy because of a significant and symptomatic stenosis of the internal carotid artery, will be enrolled. If data saturation is not reached, the sample size will be expanded. An expert medical psychologist will lead the focus group discussions. The interviews will be recorded, transcribed 'verbatim' and analyzed after each session. Items valuable to patients regarding their surgery and recovery will be discussed. This protocol will be published prior to the start of the Focus Group Discussion.

Discussion: Patients' perspective on outcomes regarding their carotid surgery will be explored and tried to be identified. The results of the focus group discussions may fuel the ongoing global discussion on improving evidence based and patient reported outcome measures and will help the clinical physician to 'understand' their patients better. Focus group discussions may aid in the purpose of verification of PROs and PROMs.

导言:颈动脉手术的结果通常使用死亡率和中风等参数进行评估。这些参数的重要性基于医生和科学的观点。目前,以患者为中心的医疗保健旨在从患者的角度重视评估,大多采用患者报告结果(PROs)。对患者而言最重要的颈动脉手术结果的真正意义在很大程度上是未知的。本研究旨在确定并验证患者对有症状且颈动脉明显狭窄的患者进行颈动脉手术的看法:作为一种高质量的研究方法,将采用探索性的半结构化焦点小组讨论。三个小组由 8 名患者(n = 24)组成,他们都因颈内动脉有明显症状性狭窄而接受了颈动脉内膜剥脱术。如果数据未达到饱和,将扩大样本量。一位医学心理学专家将主持焦点小组讨论。访谈将进行录音、"逐字 "转录,并在每次讨论后进行分析。将讨论对患者手术和康复有价值的项目。本方案将在焦点小组讨论开始前公布:讨论:将探讨患者对其颈动脉手术结果的看法,并尝试找出答案。焦点小组讨论的结果可能会推动正在进行的关于改进循证和患者报告结果测量的全球讨论,并将帮助临床医生更好地 "理解 "他们的患者。焦点小组讨论可能有助于验证PROs和PROMs的目的。
{"title":"Study Protocol for a Focus Group Discussion About the Patients' Perspective on Carotid Endarterectomy.","authors":"M S Marsman, G G Koning, B P W Jansen, M M P J Reijnen, M Habibovic, P W H E Vriens","doi":"10.1177/15385744241286585","DOIUrl":"10.1177/15385744241286585","url":null,"abstract":"<p><strong>Introduction: </strong>The outcomes of carotid surgery are commonly evaluated using parameters such as mortality and stroke. The importance of these parameters is based on doctors' and scientific perspectives. Presently, patient centered health care aims to value the evaluation from patients' perspective, mostly using Patient-Reported Outcomes (PROs). The true significance of outcomes of carotid surgery that matter most to the patients is largely unknown. The aim of this study is to identify and verify the patients' perspective on carotid surgery for patients with a symptomatic and significant carotid stenosis.</p><p><strong>Methods and outcomes: </strong>An exploratory semi-structured focus group discussion will be used, as a quality research method. Three groups consisting of 8 patients (<i>n</i> = 24), who underwent the carotid endarterectomy because of a significant and symptomatic stenosis of the internal carotid artery, will be enrolled. If data saturation is not reached, the sample size will be expanded. An expert medical psychologist will lead the focus group discussions. The interviews will be recorded, transcribed 'verbatim' and analyzed after each session. Items valuable to patients regarding their surgery and recovery will be discussed. This protocol will be published prior to the start of the Focus Group Discussion.</p><p><strong>Discussion: </strong>Patients' perspective on outcomes regarding their carotid surgery will be explored and tried to be identified. The results of the focus group discussions may fuel the ongoing global discussion on improving evidence based and patient reported outcome measures and will help the clinical physician to 'understand' their patients better. Focus group discussions may aid in the purpose of verification of PROs and PROMs.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"237-242"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GPT-4o's Accuracy in Diagnosing Aortic Aneurysms and EVAR Complications. GPT-4o 在诊断主动脉瘤和 EVAR 并发症方面的准确性。
Pub Date : 2025-04-01 Epub Date: 2024-09-30 DOI: 10.1177/15385744241290004
Muhammed Said Beşler
{"title":"GPT-4o's Accuracy in Diagnosing Aortic Aneurysms and EVAR Complications.","authors":"Muhammed Said Beşler","doi":"10.1177/15385744241290004","DOIUrl":"10.1177/15385744241290004","url":null,"abstract":"","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"347"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular Treatment of Complex Aorto-Iliac Atherosclerotic Occlusive Disease With Chimney Covered Endovascular Reconstruction of Aortic Bifurcation. 主动脉分叉处烟囱覆盖血管内重建术治疗复杂的主动脉-髂动脉粥样硬化闭塞症
Pub Date : 2025-04-01 Epub Date: 2024-10-14 DOI: 10.1177/15385744241291083
May Dvir, Fahad Shuja, Indrani Sen, Carmelina Gurrieri, Thomas Carmody, Tiziano Tallarita

Treatment of atherosclerotic occlusive disease of the infrarenal aorta poses several challenges. Traditionally, open surgery has been the preferred method of treatment in standard risk patients, although, it is burdened by high morbidity and mortality. There are many classifications to establish the patient risk for surgery. Among the most common is the American College of Cardiology (ACC)/American Heart Association (AHA) classification. ACC/AHA high-risk patients benefit from the increase in endovascular technology and skills. The treatment modality of atherosclerotic aortic disease has shifted towards a minimally invasive approach, including kissing stents, covered endovascular reconstruction of the aortic bifurcation (CERAB) and, aorto-uniiliac stent grafts. When there is an involvement of vital branches such as the inferior mesenteric (with concomitant occluded superior mesenteric artery) or the renal arteries, Chimney- CERAB technique has been successfully utilized to overcome this challenge. We present three patients with aortoiliac occlusive disease (AIOD) successfully treated with the chimney- CERAB technique to preserve a large inferior mesenteric artery in the setting of occlusion/near occlusion of the other mesenteric vessels.

肾主动脉下动脉粥样硬化性闭塞症的治疗面临诸多挑战。传统上,开腹手术是标准风险患者的首选治疗方法,但其发病率和死亡率较高。有许多分类方法可以确定患者的手术风险。其中最常见的是美国心脏病学会(ACC)/美国心脏协会(AHA)分类。ACC/AHA高风险患者受益于血管内技术和技能的提高。动脉粥样硬化性主动脉疾病的治疗模式已转向微创方法,包括吻合支架、主动脉分叉有盖血管内重建(CERAB)和主动脉-髂内支架移植物。当肠系膜下动脉(伴有肠系膜上动脉闭塞)或肾动脉等重要分支受累时,Chimney- CERAB 技术已成功用于克服这一难题。我们为您介绍三例主动脉髂闭塞症(AIOD)患者,他们在其他肠系膜血管闭塞或接近闭塞的情况下,采用 Chimney- CERAB 技术成功保留了大的肠系膜下动脉。
{"title":"Endovascular Treatment of Complex Aorto-Iliac Atherosclerotic Occlusive Disease With Chimney Covered Endovascular Reconstruction of Aortic Bifurcation.","authors":"May Dvir, Fahad Shuja, Indrani Sen, Carmelina Gurrieri, Thomas Carmody, Tiziano Tallarita","doi":"10.1177/15385744241291083","DOIUrl":"10.1177/15385744241291083","url":null,"abstract":"<p><p>Treatment of atherosclerotic occlusive disease of the infrarenal aorta poses several challenges. Traditionally, open surgery has been the preferred method of treatment in standard risk patients, although, it is burdened by high morbidity and mortality. There are many classifications to establish the patient risk for surgery. Among the most common is the American College of Cardiology (ACC)/American Heart Association (AHA) classification. ACC/AHA high-risk patients benefit from the increase in endovascular technology and skills. The treatment modality of atherosclerotic aortic disease has shifted towards a minimally invasive approach, including kissing stents, covered endovascular reconstruction of the aortic bifurcation (CERAB) and, aorto-uniiliac stent grafts. When there is an involvement of vital branches such as the inferior mesenteric (with concomitant occluded superior mesenteric artery) or the renal arteries, Chimney- CERAB technique has been successfully utilized to overcome this challenge. We present three patients with aortoiliac occlusive disease (AIOD) successfully treated with the chimney- CERAB technique to preserve a large inferior mesenteric artery in the setting of occlusion/near occlusion of the other mesenteric vessels.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"331-337"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Routine Use of Indwelling Urinary Catheters During Endovascular Abdominal Aortic Aneurysm Repair is Not Necessary. 在血管内腹主动脉瘤修补术中常规使用留置导尿管并非必要。
Pub Date : 2025-04-01 Epub Date: 2024-10-14 DOI: 10.1177/15385744241292109
Avital Simone, Lauren Carmon, Priya Rao, Meghan Cichocki, Karen Yuan, Matthew Blecha, Carlos F Bechara, Michael C Soult

Objective: Endovascular infra-renal abdominal aortic aneurysm repair (EVAR) has proven to be an effective, less invasive alternative to open aortic aneurysm repair with decreased 30-day mortality. Historically, urinary drainage catheters were routinely placed preoperatively before EVAR in our institution. A shift to reduced catheter placement has occurred in conjunction with percutaneous EVARs becoming more routine. Urethral catheterization carries risk of infection (UTI), urinary retention and prostatic trauma inducing hematuria. The purpose of this study was to evaluate whether avoidance of urinary catheter placement during EVAR is an effective practice to reduce cost and morbidity.

Methods: This was a single-institution, retrospective review of 177 consecutive patients who underwent elective infrarenal EVAR. Ruptured aneurysms and emergent EVAR were excluded. The study end points were postoperative UTI, urinary retention, length of stay, and readmission within 30 days. Univariable analysis was performed for these four outcomes in patients with (N = 92 and without (N = 65) preoperative urinary catheter placement. A more expansive multivariable investigation for risk of urinary retention following EVAR was conducted with binary logistic regression with co-variates including age, sex, femoral cutdown, estimated blood loss (EBL), urinary catheter, congestive heart failure, diabetes, and postoperative urinary retention as co-variates.

Results: Patients who had a Urinary catheter placed had an over two fold higher event rate of urinary retention (10.9% vs 4.6%) This urinary retention trend lacked power to reach significance (OR 2.52 (.665-9.55). Placement of urinary catheter also had a strong trend towards increased rate of UTI but lacking power for significance (7.6% vs 3.10%, OR 1.96 (.556-6.57). There was no difference with or without urinary catheter placement regarding 30-day readmission (yes catheter 7.6% vs no catheter 6.2%, P = .725), or length of stay (yes catheter 2.13 days vs no catheter 1.74 days, P = .723). Urinary retention was significantly associated with the development of a UTI with 23% of patients who had retention developing UTI compared with 4.2% of patients without retention developing UTI (adjusted odds ratio = 17.98, P = .019). Increased blood loss (P = .027) was also associated with increased rate of UTI on multivariable analysis.

Conclusions: Avoidance of preoperative urinary catheter placement displays a trend towards avoiding urinary retention and UTI. Patients who develop post EVAR urinary retention experience a significantly increased rate of UTI. Selective urinary catheter placement should be used to help reduce urinary-related complications following elective EVAR.

目的:血管内肾下腹主动脉瘤修补术(EVAR)已被证明是一种有效、创伤较小的主动脉瘤修补术,可替代开放性主动脉瘤修补术,并降低 30 天死亡率。一直以来,本院在 EVAR 术前都会常规放置尿液引流导管。随着经皮主动脉瓣成形术(EVAR)越来越常规,导尿管置入量也逐渐减少。尿道导尿存在感染(UTI)、尿潴留和前列腺创伤引起血尿的风险。本研究的目的是评估在 EVAR 过程中避免放置导尿管是否是降低成本和发病率的有效做法:这是一项单一机构的回顾性研究,共对 177 名连续接受择期肾下 EVAR 的患者进行了研究。排除了动脉瘤破裂和急诊EVAR患者。研究终点为术后UTI、尿潴留、住院时间和30天内再次入院。对术前放置导尿管的患者(92 人)和未放置导尿管的患者(65 人)的这四项结果进行了单变量分析。通过二元逻辑回归对EVAR术后发生尿潴留的风险进行了更广泛的多变量调查,共变因素包括年龄、性别、股骨切口、估计失血量(EBL)、导尿管、充血性心力衰竭、糖尿病和术后尿潴留:置入导尿管的患者尿潴留发生率比置入导尿管的患者高出两倍多(10.9% 对 4.6%),这种尿潴留趋势缺乏显著性(OR 2.52 (.665-9.55) )。放置导尿管也有增加尿毒症发生率的强烈趋势,但缺乏显著性(7.6% vs 3.10%,OR 1.96(.556-6.57))。在 30 天再入院方面,置入或未置入导尿管没有差异(置入导尿管为 7.6% vs 未置入导尿管为 6.2%,P = .725),住院时间也没有差异(置入导尿管为 2.13 天 vs 未置入导尿管为 1.74 天,P = .723)。尿潴留与尿毒症的发生密切相关,有尿潴留的患者中有 23% 会发生尿毒症,而没有尿潴留的患者中只有 4.2% 会发生尿毒症(调整后的几率比 = 17.98,P = .019)。在多变量分析中,失血量增加(P = .027)也与UTI发生率增加有关:结论:避免术前放置导尿管有避免尿潴留和 UTI 的趋势。EVAR术后发生尿潴留的患者UTI发生率明显增加。应选择性放置导尿管,以帮助减少择期 EVAR 术后泌尿系统相关并发症。
{"title":"Routine Use of Indwelling Urinary Catheters During Endovascular Abdominal Aortic Aneurysm Repair is Not Necessary.","authors":"Avital Simone, Lauren Carmon, Priya Rao, Meghan Cichocki, Karen Yuan, Matthew Blecha, Carlos F Bechara, Michael C Soult","doi":"10.1177/15385744241292109","DOIUrl":"10.1177/15385744241292109","url":null,"abstract":"<p><strong>Objective: </strong>Endovascular infra-renal abdominal aortic aneurysm repair (EVAR) has proven to be an effective, less invasive alternative to open aortic aneurysm repair with decreased 30-day mortality. Historically, urinary drainage catheters were routinely placed preoperatively before EVAR in our institution. A shift to reduced catheter placement has occurred in conjunction with percutaneous EVARs becoming more routine. Urethral catheterization carries risk of infection (UTI), urinary retention and prostatic trauma inducing hematuria. The purpose of this study was to evaluate whether avoidance of urinary catheter placement during EVAR is an effective practice to reduce cost and morbidity.</p><p><strong>Methods: </strong>This was a single-institution, retrospective review of 177 consecutive patients who underwent elective infrarenal EVAR. Ruptured aneurysms and emergent EVAR were excluded. The study end points were postoperative UTI, urinary retention, length of stay, and readmission within 30 days. Univariable analysis was performed for these four outcomes in patients with (N = 92 and without (N = 65) preoperative urinary catheter placement. A more expansive multivariable investigation for risk of urinary retention following EVAR was conducted with binary logistic regression with co-variates including age, sex, femoral cutdown, estimated blood loss (EBL), urinary catheter, congestive heart failure, diabetes, and postoperative urinary retention as co-variates.</p><p><strong>Results: </strong>Patients who had a Urinary catheter placed had an over two fold higher event rate of urinary retention (10.9% vs 4.6%) This urinary retention trend lacked power to reach significance (OR 2.52 (.665-9.55). Placement of urinary catheter also had a strong trend towards increased rate of UTI but lacking power for significance (7.6% vs 3.10%, OR 1.96 (.556-6.57). There was no difference with or without urinary catheter placement regarding 30-day readmission (yes catheter 7.6% vs no catheter 6.2%, <i>P</i> = .725), or length of stay (yes catheter 2.13 days vs no catheter 1.74 days, <i>P</i> = .723). Urinary retention was significantly associated with the development of a UTI with 23% of patients who had retention developing UTI compared with 4.2% of patients without retention developing UTI (adjusted odds ratio = 17.98, <i>P</i> = .019). Increased blood loss (<i>P</i> = .027) was also associated with increased rate of UTI on multivariable analysis.</p><p><strong>Conclusions: </strong>Avoidance of preoperative urinary catheter placement displays a trend towards avoiding urinary retention and UTI. Patients who develop post EVAR urinary retention experience a significantly increased rate of UTI. Selective urinary catheter placement should be used to help reduce urinary-related complications following elective EVAR.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"271-276"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Aortic Malignant Peripheral Nerve Sheath Tumor. 原发性主动脉恶性周围神经鞘瘤
Pub Date : 2025-04-01 Epub Date: 2024-09-30 DOI: 10.1177/15385744241290014
Hisaya Mori, Hisato Takagi

A 74 year-old woman suffering 1 month persisting lumbago was referred with diagnosis of thoracic aortic aneurysm. Blood examinations indicated slightly or moderately elevated noradrenaline, dopamine, and homovanillic acid with normal-range vanillylmandelic acid. Contrast-enhanced CT scans revealed a tumor, protruding both intra- and extra-luminally, in the wall of the distal descending thoracic aorta without any primary focuses in the whole body. Primary aortic sarcoma or periaortic catecholamine-producing paraganglioma infiltrating the aorta was suspected. The tumor with the normal proximal and distal aorta 2-3 cm apart from it was completely resected under femoro-femoral partial cardiopulmonary bypass. Macroscopically, the tumor was originated from the aortic wall and protruded both intra- and extra-luminally. Immunohistochemically, positive S-100 and vimentin; Ki67 levels of 40%; and negative CD34, CK AE1/AE3, and SMA were identified. The aforementioned findings definitively diagnosed primary aortic malignant peripheral nerve sheath tumor, which has been never reported in the literature.

一名 74 岁的妇女腰痛持续 1 个月后被转诊,诊断为胸主动脉瘤。血液检查显示去甲肾上腺素、多巴胺和高香草酸轻度或中度升高,香草酸正常。对比增强 CT 扫描显示,远端降胸主动脉壁上有一个突出于腔内和腔外的肿瘤,全身没有任何原发病灶。怀疑是原发性主动脉肉瘤或主动脉周围儿茶酚胺生成副神经节瘤浸润主动脉。在股-股部分心肺旁路手术下,完全切除了肿瘤及其相距 2-3 厘米的正常近端和远端主动脉。显微镜下,肿瘤起源于主动脉壁,向腔内和腔外突出。免疫组化结果显示,S-100 和波形蛋白阳性,Ki67 水平为 40%,CD34、CK AE1/AE3 和 SMA 阴性。上述结果明确诊断为原发性主动脉恶性周围神经鞘瘤,而这在文献中从未报道过。
{"title":"Primary Aortic Malignant Peripheral Nerve Sheath Tumor.","authors":"Hisaya Mori, Hisato Takagi","doi":"10.1177/15385744241290014","DOIUrl":"10.1177/15385744241290014","url":null,"abstract":"<p><p>A 74 year-old woman suffering 1 month persisting lumbago was referred with diagnosis of thoracic aortic aneurysm. Blood examinations indicated slightly or moderately elevated noradrenaline, dopamine, and homovanillic acid with normal-range vanillylmandelic acid. Contrast-enhanced CT scans revealed a tumor, protruding both intra- and extra-luminally, in the wall of the distal descending thoracic aorta without any primary focuses in the whole body. Primary aortic sarcoma or periaortic catecholamine-producing paraganglioma infiltrating the aorta was suspected. The tumor with the normal proximal and distal aorta 2-3 cm apart from it was completely resected under femoro-femoral partial cardiopulmonary bypass. Macroscopically, the tumor was originated from the aortic wall and protruded both intra- and extra-luminally. Immunohistochemically, positive S-100 and vimentin; Ki67 levels of 40%; and negative CD34, CK AE1/AE3, and SMA were identified. The aforementioned findings definitively diagnosed primary aortic malignant peripheral nerve sheath tumor, which has been never reported in the literature.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"309-314"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Branched EVAR in Treatment of Juxtarenal Aortic Aneurysm and Essential Accessory Renal Artery: Another Tool on the Shelf? A Case Report. 使用分支EVAR治疗并arenal主动脉瘤和重要肾动脉:货架上的另一种工具?病例报告。
Pub Date : 2025-04-01 Epub Date: 2024-10-04 DOI: 10.1177/15385744241290011
Donatas Opulskis, Imam T P Ritonga, Philipp Franke, Martin J Austermann, Marco Virgilio Usai

Objective: We present the case of a 58-year-old male patient referred to our department from a smaller facility for further evaluation and treatment strategy regarding the choice between open or endovascular surgery. The patient was diagnosed with a 6 cm asymptomatic juxtarenal aortic aneurysm and a 5 mm diameter accessory renal artery (ARA) supplying the lower half of left kidney. Further diagnostic assessments indicated that the left ARA was perfusing over 40% of the left kidney.

Methods: Given the patient's significant pre-existing medical conditions and elevated perioperative risk, the decision was made to proceed with minimally invasive endovascular surgery using a custom-made 5-branches stent graft (BEVAR).

Results: In the early postoperative period, the patient reported left flank pain. A subsequent CT scan identified a partial infarction in the left kidney due to the occlusion of an early small branch from the upper left renal artery. However, laboratory results showed no significant change in renal function compared to preoperative values. The patient was discharged 6 days post-surgery, with no additional complications observed during the early postoperative period.

Conclusion: This case report demonstrates that BEVAR is acceptable technique with satisfactory early postoperative outcomes for treating juxtarenal aortic aneurysms with an accessory renal artery in patients who are high-risk candidates for open repair and anatomically unsuitable for FEVAR or Ch-EVAR procedures.

目的:本病例是一名 58 岁的男性患者,从一家较小的医疗机构转诊至我科,就选择开放手术还是血管内手术进行进一步评估并制定治疗策略。患者被诊断出患有一个 6 厘米无症状的并肾主动脉瘤和一个直径为 5 毫米的供应左肾下半部的附属肾动脉(ARA)。进一步的诊断评估表明,左侧 ARA 供应了 40% 以上的左肾:考虑到患者原有的严重病症和围手术期的高风险,决定使用定制的 5 支支架移植物(BEVAR)进行微创血管内手术:术后早期,患者报告左侧腹部疼痛。随后的 CT 扫描发现,由于左肾上动脉的一条早期小分支闭塞,导致左肾部分梗死。然而,化验结果显示肾功能与术前相比没有明显变化。患者术后 6 天出院,术后早期未发现其他并发症:本病例报告表明,BEVAR 是一种可接受的技术,可用于治疗伴有附属肾动脉的并肾主动脉瘤,术后早期疗效令人满意,适用于开放式修复术的高风险候选者,以及在解剖上不适合 FEVAR 或 Ch-EVAR 手术的患者。
{"title":"Use of Branched EVAR in Treatment of Juxtarenal Aortic Aneurysm and Essential Accessory Renal Artery: Another Tool on the Shelf? A Case Report.","authors":"Donatas Opulskis, Imam T P Ritonga, Philipp Franke, Martin J Austermann, Marco Virgilio Usai","doi":"10.1177/15385744241290011","DOIUrl":"10.1177/15385744241290011","url":null,"abstract":"<p><strong>Objective: </strong>We present the case of a 58-year-old male patient referred to our department from a smaller facility for further evaluation and treatment strategy regarding the choice between open or endovascular surgery. The patient was diagnosed with a 6 cm asymptomatic juxtarenal aortic aneurysm and a 5 mm diameter accessory renal artery (ARA) supplying the lower half of left kidney. Further diagnostic assessments indicated that the left ARA was perfusing over 40% of the left kidney.</p><p><strong>Methods: </strong>Given the patient's significant pre-existing medical conditions and elevated perioperative risk, the decision was made to proceed with minimally invasive endovascular surgery using a custom-made 5-branches stent graft (BEVAR).</p><p><strong>Results: </strong>In the early postoperative period, the patient reported left flank pain. A subsequent CT scan identified a partial infarction in the left kidney due to the occlusion of an early small branch from the upper left renal artery. However, laboratory results showed no significant change in renal function compared to preoperative values. The patient was discharged 6 days post-surgery, with no additional complications observed during the early postoperative period.</p><p><strong>Conclusion: </strong>This case report demonstrates that BEVAR is acceptable technique with satisfactory early postoperative outcomes for treating juxtarenal aortic aneurysms with an accessory renal artery in patients who are high-risk candidates for open repair and anatomically unsuitable for FEVAR or Ch-EVAR procedures.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"303-308"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Pedal Bypass in a Patient With Pseudoxanthoma Elasticum. 成功为一名假黄瘤患者实施迂回手术
Pub Date : 2025-04-01 Epub Date: 2024-10-13 DOI: 10.1177/15385744241290007
Suvi Väärämäki, Olli Hautero, Vesa Rajala, Pasi Nevalainen

Objectives: Pseudoxanthoma elasticum (PXE) is a rare metabolic disease, causing calcification in the arterial media layer and further peripheral artery disease (PAD). A high rate of failure has been reported after endovascular and open surgical management of PAD among patients with PXE. Critical limb ischemia (CLI) rarely develops in PXE, and there are only few reports of its treatment.

Methods: We present a case report of a 57 year-old female diagnosed with pseudoxanthoma elasticum (PXE). She presented with critical limb ischemia (CLI) and was successfully treated with pedal bypass using the great saphenous vein.

Results: Despite obtaining suboptimal outcomes through the initial approach of percutaneous transluminal angioplasty to treat critical limb ischemia, the subsequent bypass operation proved to be a success. At the first follow-up appointment at 1 month, the patient was asymptomatic and the ulceration had almost healed. The patient underwent an ultrasound examination at 3, 6, 12, and 24 months after discharge, and the surveillance was uncomplicated.

Conclusions: With a clear indication for surgery, limb-threatening ischemia can be successfully treated with distal bypass, if necessary, in patients with PXE similarly to atherosclerotic PADs. Appropriate diagnostic and surveillance imaging and the utilization of a multidisciplinary team are key components for effective management of PAD in patients with PXE.

目的:假黄疽弹性瘤(PXE)是一种罕见的代谢性疾病,会导致动脉介质层钙化,进一步引发外周动脉疾病(PAD)。据报道,PXE 患者在接受血管内和开放手术治疗 PAD 后,失败率很高。PXE患者很少出现严重肢体缺血(CLI),关于其治疗方法的报道也寥寥无几:我们报告了一例 57 岁女性假黄瘤患者的病例。她出现了严重的肢体缺血(CLI),并成功地通过大隐静脉进行了足部搭桥治疗:结果:尽管最初采用经皮腔内血管成形术治疗危重肢体缺血的效果并不理想,但随后的搭桥手术证明是成功的。在1个月后的首次复诊中,患者没有任何症状,溃疡也基本愈合。患者在出院后3、6、12和24个月分别接受了超声波检查,监测结果均无异常:结论:在有明确手术指征的情况下,PXE 患者与动脉粥样硬化性 PAD 患者一样,必要时可通过远端搭桥手术成功治疗危及肢体的缺血。适当的诊断和监测成像以及利用多学科团队是有效治疗 PXE 患者 PAD 的关键要素。
{"title":"Successful Pedal Bypass in a Patient With Pseudoxanthoma Elasticum.","authors":"Suvi Väärämäki, Olli Hautero, Vesa Rajala, Pasi Nevalainen","doi":"10.1177/15385744241290007","DOIUrl":"10.1177/15385744241290007","url":null,"abstract":"<p><strong>Objectives: </strong>Pseudoxanthoma elasticum (PXE) is a rare metabolic disease, causing calcification in the arterial media layer and further peripheral artery disease (PAD). A high rate of failure has been reported after endovascular and open surgical management of PAD among patients with PXE. Critical limb ischemia (CLI) rarely develops in PXE, and there are only few reports of its treatment.</p><p><strong>Methods: </strong>We present a case report of a 57 year-old female diagnosed with pseudoxanthoma elasticum (PXE). She presented with critical limb ischemia (CLI) and was successfully treated with pedal bypass using the great saphenous vein.</p><p><strong>Results: </strong>Despite obtaining suboptimal outcomes through the initial approach of percutaneous transluminal angioplasty to treat critical limb ischemia, the subsequent bypass operation proved to be a success. At the first follow-up appointment at 1 month, the patient was asymptomatic and the ulceration had almost healed. The patient underwent an ultrasound examination at 3, 6, 12, and 24 months after discharge, and the surveillance was uncomplicated.</p><p><strong>Conclusions: </strong>With a clear indication for surgery, limb-threatening ischemia can be successfully treated with distal bypass, if necessary, in patients with PXE similarly to atherosclerotic PADs. Appropriate diagnostic and surveillance imaging and the utilization of a multidisciplinary team are key components for effective management of PAD in patients with PXE.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"315-319"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804138/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asymptomatic Carotid Stenosis is Associated With Mobility Dysfunction: Results From the InChianti Study.
Pub Date : 2025-02-27 DOI: 10.1177/15385744251323434
Sarasijhaa K Desikan, James Borrelli, Vicki L Gray, Aman A Kankaria, Michael Terrin, Brajesh K Lal

Background: Older adults with mobility dysfunction are at risk for falls, hospitalization, and death. In an earlier pilot study, individuals with asymptomatic carotid artery stenosis (ACAS) demonstrated mobility dysfunction when compared to individuals without ACAS. We tested whether carotid stenosis affected mobility function in a larger community-dwelling cohort using the Invecchaire in Chianti (InCHIANTI) database.

Methods: We analyzed data from participants in the InCHIANTI study who completed a medical history, carotid duplex testing, and mobility function testing (Short Physical Performance Battery- SPPB). Participants with a history of stroke, transient ischemic attack, or carotid endarterectomy were excluded. 709 participants met inclusion criteria (116 ACAS, 593 no ACAS). Our analytic approach sought to evaluate the impact of stenosis on mobility after accounting for age, sex and cardiovascular risk factors. Age was stratified into 2 age-groups (65-74 and 75-84 years). Two-way ANOVA was used to test the effect of stenosis-group, age-group, and their interactions on SPPB score with sex as a covariate.

Results: Stenosis-group (P = 0.0002), age-group (P < 0.0001), and the interaction between stenosis-group and age-group (P = 0.0008) significantly affected SPPB. Post-hoc testing showed that participants with ACAS demonstrated worse performance on the SPPB (9.81 ± 0.37) compared to those with no ACAS (11.10 ± 0.11) in the 65-74 years age-group (P < 0.0001).

Conclusions: 65-74-year-old adults with ACAS performed significantly worse on the SPPB than those without ACAS. These results lend further support that ACAS may be associated with mobility dysfunction in older adults.

{"title":"Asymptomatic Carotid Stenosis is Associated With Mobility Dysfunction: Results From the InChianti Study.","authors":"Sarasijhaa K Desikan, James Borrelli, Vicki L Gray, Aman A Kankaria, Michael Terrin, Brajesh K Lal","doi":"10.1177/15385744251323434","DOIUrl":"https://doi.org/10.1177/15385744251323434","url":null,"abstract":"<p><strong>Background: </strong>Older adults with mobility dysfunction are at risk for falls, hospitalization, and death. In an earlier pilot study, individuals with asymptomatic carotid artery stenosis (ACAS) demonstrated mobility dysfunction when compared to individuals without ACAS. We tested whether carotid stenosis affected mobility function in a larger community-dwelling cohort using the Invecchaire in Chianti (InCHIANTI) database.</p><p><strong>Methods: </strong>We analyzed data from participants in the InCHIANTI study who completed a medical history, carotid duplex testing, and mobility function testing (Short Physical Performance Battery- SPPB). Participants with a history of stroke, transient ischemic attack, or carotid endarterectomy were excluded. 709 participants met inclusion criteria (116 ACAS, 593 no ACAS). Our analytic approach sought to evaluate the impact of stenosis on mobility after accounting for age, sex and cardiovascular risk factors. Age was stratified into 2 age-groups (65-74 and 75-84 years). Two-way ANOVA was used to test the effect of stenosis-group, age-group, and their interactions on SPPB score with sex as a covariate.</p><p><strong>Results: </strong>Stenosis-group (<i>P</i> = 0.0002), age-group (<i>P</i> < 0.0001), and the interaction between stenosis-group and age-group (<i>P</i> = 0.0008) significantly affected SPPB. Post-hoc testing showed that participants with ACAS demonstrated worse performance on the SPPB (9.81 ± 0.37) compared to those with no ACAS (11.10 ± 0.11) in the 65-74 years age-group (<i>P <</i> 0.0001).</p><p><strong>Conclusions: </strong>65-74-year-old adults with ACAS performed significantly worse on the SPPB than those without ACAS. These results lend further support that ACAS may be associated with mobility dysfunction in older adults.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"15385744251323434"},"PeriodicalIF":0.0,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143525658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Stent Vein Lumen Shape and Clinical Response in Patients Treated for Iliofemoral Venous Occlusive Disease.
Pub Date : 2025-02-18 DOI: 10.1177/15385744251321900
Paul Gagne, Kayode O Kuku, Robert Mendes, Amy Griggs, Edem Segbefia, Lawrence V Hofmann, Anthony Comerota, Hector M Garcia-Garcia

Objective: Interventionalists have noted significant venous luminal gain with nitinol venous stents although post-placement lumen shape differed from the circular shape observed with elgiloy stents. The goal of this study was to determine the characteristics of a stented vein lumen that correspond with clinical outcomes, and to identify metrics that might be relevant for stent design by assessing aspect ratio (AR), lumen diameter (LD), lumen area (LA), and stent shape (symmetry and eccentricity) post-implant.

Methods: This post-hoc analysis evaluated patients from the VIVO US Study (NCT01970007) with pre- and post-stent intravascular ultrasound (IVUS) imaging. Patient characteristics, Venous Clinical Severity Score (VCSS) and Venous Disability Score (VDS) were collected in the study. LD, LA, and stent geometry were measured by the core laboratory. Data were analyzed for linear association between core-laboratory assessed pre and post stent LD, LA, AR, stent eccentricity and symmetry index, and VCSS and VDS change.

Results: IVUS imaging was available for 29 patients (2 sites) enrolled in the VIVO US Study (55.2% women; mean age: 59.8 ± 17 years). The cohort had post-thrombotic (48.3%), nonthrombotic iliac vein lesion (44.8%) or acute deep vein thrombotic (6.9%) disease. Mean lesion length was 111.8 ± 60.9 mm. Eleven stents extended below the inguinal ligament. Median minimum LD and LA significantly increased after stent placement (P < 0.001); median lumen AR changed from 2.0 pre-stent to 1.4 post-stent (P < 0.001). Mean VCSS improved from baseline to 12 months (7.6 ± 4.3 to 3.7 ± 2.6). No statistically significant linear relationships were identified between VCSS / VDS change and a specific characteristic of LA, LD, or AR.

Conclusions: Measures of lumen change pre and post iliofemoral vein nitinol stent placement reflect disease and stent characteristics. After stent placement, minimum LD and LA increased and AR decreased. Stented lumen shape or size with Zilver Vena did not impact 1-year clinical improvement by VCSS.

目的:介入专家注意到镍钛诺静脉支架能显著增加静脉管腔,但置入后的管腔形状与使用埃吉洛伊支架观察到的圆形不同。本研究的目的是确定与临床结果相对应的支架静脉管腔特征,并通过评估支架植入后的长宽比(AR)、管腔直径(LD)、管腔面积(LA)和支架形状(对称性和偏心率),确定可能与支架设计相关的指标:这项事后分析评估了 VIVO US 研究 (NCT01970007) 患者支架植入前后的血管内超声 (IVUS) 成像。研究收集了患者特征、静脉临床严重程度评分(VCSS)和静脉残疾评分(VDS)。核心实验室对 LD、LA 和支架几何形状进行了测量。对数据进行分析,以确定核心实验室评估的支架前后LD、LA、AR、支架偏心率和对称性指数以及VCSS和VDS变化之间的线性关系:参加 VIVO US 研究的 29 名患者(2 个地点)(55.2% 为女性;平均年龄:59.8 ± 17 岁)均获得了 IVUS 成像。这些患者有血栓后(48.3%)、非血栓性髂静脉病变(44.8%)或急性深静脉血栓(6.9%)疾病。病变平均长度为 111.8 ± 60.9 毫米。有 11 个支架延伸至腹股沟韧带以下。支架置入后,中位最小LD和LA明显增加(P < 0.001);中位管腔AR从支架置入前的2.0变为支架置入后的1.4(P < 0.001)。平均 VCSS 从基线到 12 个月有所改善(7.6 ± 4.3 到 3.7 ± 2.6)。VCSS/VDS变化与LA、LD或AR的特定特征之间未发现有统计学意义的线性关系:结论:髂股静脉镍钛诺支架置入前后的管腔变化反映了疾病和支架的特征。放置支架后,最小 LD 和 LA 增加,AR 减少。使用 Zilver Vena 支架的管腔形状或大小不会影响 VCSS 1 年的临床改善。
{"title":"Post-Stent Vein Lumen Shape and Clinical Response in Patients Treated for Iliofemoral Venous Occlusive Disease.","authors":"Paul Gagne, Kayode O Kuku, Robert Mendes, Amy Griggs, Edem Segbefia, Lawrence V Hofmann, Anthony Comerota, Hector M Garcia-Garcia","doi":"10.1177/15385744251321900","DOIUrl":"https://doi.org/10.1177/15385744251321900","url":null,"abstract":"<p><strong>Objective: </strong>Interventionalists have noted significant venous luminal gain with nitinol venous stents although post-placement lumen shape differed from the circular shape observed with elgiloy stents. The goal of this study was to determine the characteristics of a stented vein lumen that correspond with clinical outcomes, and to identify metrics that might be relevant for stent design by assessing aspect ratio (AR), lumen diameter (LD), lumen area (LA), and stent shape (symmetry and eccentricity) post-implant.</p><p><strong>Methods: </strong>This post-hoc analysis evaluated patients from the VIVO US Study (NCT01970007) with pre- and post-stent intravascular ultrasound (IVUS) imaging. Patient characteristics, Venous Clinical Severity Score (VCSS) and Venous Disability Score (VDS) were collected in the study. LD, LA, and stent geometry were measured by the core laboratory. Data were analyzed for linear association between core-laboratory assessed pre and post stent LD, LA, AR, stent eccentricity and symmetry index, and VCSS and VDS change.</p><p><strong>Results: </strong>IVUS imaging was available for 29 patients (2 sites) enrolled in the VIVO US Study (55.2% women; mean age: 59.8 ± 17 years). The cohort had post-thrombotic (48.3%), nonthrombotic iliac vein lesion (44.8%) or acute deep vein thrombotic (6.9%) disease. Mean lesion length was 111.8 ± 60.9 mm. Eleven stents extended below the inguinal ligament. Median minimum LD and LA significantly increased after stent placement (<i>P</i> < 0.001); median lumen AR changed from 2.0 pre-stent to 1.4 post-stent (<i>P</i> < 0.001). Mean VCSS improved from baseline to 12 months (7.6 ± 4.3 to 3.7 ± 2.6). No statistically significant linear relationships were identified between VCSS / VDS change and a specific characteristic of LA, LD, or AR.</p><p><strong>Conclusions: </strong>Measures of lumen change pre and post iliofemoral vein nitinol stent placement reflect disease and stent characteristics. After stent placement, minimum LD and LA increased and AR decreased. Stented lumen shape or size with Zilver Vena did not impact 1-year clinical improvement by VCSS.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"15385744251321900"},"PeriodicalIF":0.0,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143451359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparities in Aortic Aneurysm Mortality Trends: Revealing Sex and Racial Inequalities.
Pub Date : 2025-02-14 DOI: 10.1177/15385744251321621
Masashi Azuma, Andrew Ramirez, G William Moser, Kenny J Oh, Mohammed Abul Kashem, Yoshiya Toyoda, Suyog Mokashi

Background: Abdominal aortic dissection or aneurysm (AAA) is a significant health concern in developed nations often underdiagnosed with poor outcomes. Despite a decline in aortic dissection and aneurysm mortality rates in the US from 1999 to 2020, reported by the CDC, this improvement disproportionately favors males and Caucasians. This study aims to elucidate these disparities.

Methods: Data from the CDC Wonder database from 1999 to 2020 on aortic aneurysm, including abdominal, thoracic, and thoracoabdominal aneurysms and rupture related deaths in the US were analyzed. Mortality rates were compared across sex, race, and geographic location separated by state. Mortality was normalized based on population and analyzed with linear regression models with all plots showing goodness of fit.

Results: Overall, the mortality gap between male and female cohorts with aortic aneurysm-related deaths widened by 0.57 per 100,000 deaths per year (P < 0.001). Mortality between Caucasians with African American and Asian American cohorts showed reductions of 0.41 per 100,000 per year (P < 0.001). Caucasian and male cohorts started at higher mortality rates when compared to their competitive cohorts.

Conclusions: Despite a reduction in mortality rates among individuals with aortic aneurysm in the US from 1999 to 2020, this decline disproportionately benefits males and Caucasians over African American and Asian populations. Although Caucasians and males had higher mortality in 1999, their decline is significantly greater. Following current trends, Caucasian and male mortalities will be lower than minority groups by 2026. Targeted interventions are needed to address these disparities effectively.

{"title":"Disparities in Aortic Aneurysm Mortality Trends: Revealing Sex and Racial Inequalities.","authors":"Masashi Azuma, Andrew Ramirez, G William Moser, Kenny J Oh, Mohammed Abul Kashem, Yoshiya Toyoda, Suyog Mokashi","doi":"10.1177/15385744251321621","DOIUrl":"https://doi.org/10.1177/15385744251321621","url":null,"abstract":"<p><strong>Background: </strong>Abdominal aortic dissection or aneurysm (AAA) is a significant health concern in developed nations often underdiagnosed with poor outcomes. Despite a decline in aortic dissection and aneurysm mortality rates in the US from 1999 to 2020, reported by the CDC, this improvement disproportionately favors males and Caucasians. This study aims to elucidate these disparities.</p><p><strong>Methods: </strong>Data from the CDC Wonder database from 1999 to 2020 on aortic aneurysm, including abdominal, thoracic, and thoracoabdominal aneurysms and rupture related deaths in the US were analyzed. Mortality rates were compared across sex, race, and geographic location separated by state. Mortality was normalized based on population and analyzed with linear regression models with all plots showing goodness of fit.</p><p><strong>Results: </strong>Overall, the mortality gap between male and female cohorts with aortic aneurysm-related deaths widened by 0.57 per 100,000 deaths per year (<i>P</i> < 0.001). Mortality between Caucasians with African American and Asian American cohorts showed reductions of 0.41 per 100,000 per year (<i>P</i> < 0.001). Caucasian and male cohorts started at higher mortality rates when compared to their competitive cohorts.</p><p><strong>Conclusions: </strong>Despite a reduction in mortality rates among individuals with aortic aneurysm in the US from 1999 to 2020, this decline disproportionately benefits males and Caucasians over African American and Asian populations. Although Caucasians and males had higher mortality in 1999, their decline is significantly greater. Following current trends, Caucasian and male mortalities will be lower than minority groups by 2026. Targeted interventions are needed to address these disparities effectively.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"15385744251321621"},"PeriodicalIF":0.0,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143417129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vascular and endovascular surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1